AT 56Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are essentially the most maturely formulated TPD procedures. During this evaluate, we center on the two preclinical experiments and scientific trials to deliver an extensive summary of the security and scientific effectiveness of PROTACs and MGDs in hematologic malign